# Karyopharm Therapeutics Inc.: Form 8-K, filed Sep 18, 2026

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2026-09-18
- Accepted by EDGAR: Sep 18, 2026, 16:05 ET
- Period: 2026-09-17
- Accession: 0001193125-26-395517
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000119312526395517/d141487d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000119312526395517/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000119312526395517/d141487d8k.htm

Filed Sep 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-395517. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
